Clinical Endpoints in Allogeneic Hematopoietic Stem Cell Transplantation Studies: The Cost of Freedom

Por Kim, Haesook T., Armand, Philippe
Publicado em 2013

Three-Component Cure Rate Model for Non-Proportional Hazards Alternative in the Design of Randomized Clinical Trials

Por Kim, Haesook Teresa, Gray, Robert
Publicado em 2012

Sirolimus, tacrolimus and low-dose methotrexate as graft versus host disease prophylaxis in related and unrelated donor reduced intensity conditioning allogeneic peripheral blood s...

Por Alyea, Edwin P., Li, Shuli, Kim, Haesook T., Cutler, Corey, Ho, Vincent, Soiffer, Robert J., Antin, Joseph H.
Publicado em 2008

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

Por Armand, Philippe, Kim, Haesook T., Cutler, Corey S., Ho, Vincent T., Koreth, John, Alyea, Edwin P., Soiffer, Robert J., Antin, Joseph H.
Publicado em 2007

Multicenter Validation Study of a Transplantation-Specific Cytogenetics Grouping Scheme for Patients with Myelodysplastic Syndromes

Por Armand, Philippe, Deeg, H. Joachim, Kim, Haesook T., Lee, Hun, Armistead, Paul, de Lima, Marcos, Gupta, Vikas, Soiffer, Robert J.
Publicado em 2009

High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease

Por Sarantopoulos, Stefanie, Stevenson, Kristen E., Kim, Haesook T., Bhuiya, Nazmim S., Cutler, Corey S., Soiffer, Robert J., Antin, Joseph H., Ritz, Jerome
Publicado em 2007

ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA WHO ACHIEVE COMPLETE REMISSION AFTER ONE OR TWO CYCLES OF INDUCTION HAVE A SIMILAR PROGNOSIS: A REPORT ON 1,980 PATIENTS REGISTERED TO SI...

Por Rowe, Jacob M., Kim, Haesook T., Cassileth, Peter A., Lazarus, Hillard M., Litzow, Mark R., Wiernik, Peter H., Tallman, Martin S.
Publicado em 2010

A Prognostic Score for Patients with Acute Leukemia or Myelodysplastic Syndromes Undergoing Allogeneic Stem Cell Transplantation

Por Armand, Philippe, Kim, Haesook T., Cutler, Corey S., Ho, Vincent T., Koreth, John, Ritz, Jerome, Alyea, Edwin P., Antin, Joseph H., Soiffer, Robert J.
Publicado em 2007

Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/Mtx) as Acute GVHD Prophylaxis after Reduced Intensity Conditioning Al...

Por Ho, Vincent T., Aldridge, Julie, Kim, Haesook T., Cutler, Corey, Koreth, John, Armand, Philippe, Antin, Joseph H., Soiffer, Robert J., Alyea, Edwin P.
Publicado em 2009

Outcome and Prognostic Factors for Patients Who Relapse After Allogeneic Stem Cell Transplantation

Por Thanarajasingam, Gita, Kim, Haesook T., Cutler, Corey, Ho, Vincent T., Koreth, John, Alyea, Edwin P., Antin, Joseph H., Soiffer, Robert J., Armand, Philippe
Publicado em 2013

Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation

Por Zorn, Emmanuel, Mohseni, Mehrdad, Kim, Haesook, Porcheray, Fabrice, Lynch, Allison, Bellucci, Roberto, Canning, Christine, Alyea, Edwin P., Soiffer, Robert J., Ritz, Jerome
Publicado em 2009

IL-7 and SCF Levels Inversely Correlate with T Cell Reconstitution and Clinical Outcomes after Cord Blood Transplantation in Adults

Por Politikos, Ioannis, Kim, Haesook T., Nikiforow, Sarah, Li, Lequn, Brown, Julia, Antin, Joseph H., Cutler, Corey, Ballen, Karen, Ritz, Jerome, Boussiotis, Vassiliki A.
Publicado no PLoS One (2015)

Donor and recipient sex in allogeneic stem cell transplantation: what really matters

Por Kim, Haesook T., Zhang, Mei-Jie, Woolfrey, Ann E., St. Martin, Andrew, Chen, Junfang, Saber, Wael, Perales, Miguel-Angel, Armand, Philippe, Eapen, Mary
Publicado no Haematologica (2016)

Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced Age

Por Koreth, John, Aldridge, Julie, Kim, Haesook T., Alyea, Edwin P., Cutler, Corey, Armand, Philippe, Ritz, Jerome, Antin, Joseph H., Soiffer, Robert J., Ho, Vincent T.
Publicado em 2010

PROGNOSTIC IMPLICATIONS OF ADDITIONAL CHROMOSOME ABNORMALITIES AMONG PATIENTS WITH DE NOVO ACUTE PROMYELOCYTIC LEUKAEMIA WITH t(15;17)

Por Wiernik, Peter H., Sun, Zhuoxin, Gundacker, Holly, Dewald, Gordon, Slovak, Marilyn L., Paietta, Elisabeth, Kim, Haesook T., Appelbaum, Frederick R., Cassileth, Peter A., Tallman, Martin S.
Publicado em 2012

Hyperlipidemia and Statin Use after Allogeneic Hematopoietic Stem Cell Transplantation

Por Blaser, Bradley W., Kim, Haesook T., Alyea, Edwin P., Ho, Vincent T., Cutler, Corey, Armand, Philippe, Koreth, John, Antin, Joseph H., Plutzky, Jorge, Soiffer, Robert J.
Publicado em 2011

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors

Por Miklos, David B., Kim, Haesook T., Zorn, Emmanuel, Hochberg, Ephraim P., Guo, Luxuan, Mattes-Ritz, Alex, Viatte, Sebastien, Soiffer, Robert J., Antin, Joseph H., Ritz, Jerome
Publicado em 2003

Peripheral Blood Progenitor Cell Product Contains Th1-Biased Non-Invariant CD1d-Reactive NKT Cells: Implications for Post-Transplant Survival

Por Shaulov, Angela, Yue, Simon, Wang, RuoJie, Joyce, Robin M., Balk, Steven P., Kim, Haesook T., Avigan, David E., Uhl, Lynne, Sackstein, Robert, Exley, Mark A.
Publicado em 2008

The Impact of Geographic Proximity to Transplant Center on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation

Por Abou-Nassar, Karim E., Kim, Haesook T., Blossom, Jeff, Ho, Vincent T., Soiffer, Robert J., Cutler, Corey S., Alyea, Edwin P., Koreth, John, Antin, Joseph H., Armand, Philippe
Publicado em 2011

Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantation

Por Kekre, Natasha, Kim, Haesook T., Thanarajasingam, Gita, Armand, Philippe, Antin, Joseph H., Cutler, Corey, Nikiforow, Sarah, Ho, Vincent T., Koreth, John, Alyea, Edwin P., Soiffer, Robert J.
Publicado no Haematologica (2015)